News tagged with immune thrombocytopenic purpura

Medications

FDA approves cablivi for rare blood-clotting disorder

(HealthDay)—Cablivi (caplacizumab-yhdp) injection has been approved by the U.S. Food and Drug Administration to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP).

Feb 7, 2019

0

3
Medications

Promacta approval expanded to kids with rare blood disorder

(HealthDay)—U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children one year and older with a rare blood disorder called chronic immune thrombocytopenic purpura ...

Aug 24, 2015

0

5